GenSight Biologics Companies
GenSight Biologics develops gene therapies for neurodegenerative and ophthalmic diseases. Their innovative treatments aim to restore vision and neuronal function, improving the quality of life and addressing aging-related degenerative conditions.
Investors
Industry:
Biotechnology, Heath and Wellness Technology
Estimated Revenue:
€1.34 MillionAccording
Headquarters:
France, Paris
Founded Date:
2012